Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 91

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 91
---
 American College of Wound
Care Specialists and has served as advisor and consultant to leading global public and private companies.

Ronald W. Millerserves as the Chair of the
Board of Directors. Ronnie Miller was President and CEO of Hoffmann-La Roche Limited (Roche Canada) for 22 years (until 2022). In this
role, he was responsible for the growth and success of the Canadian Pharmaceuticals Division, particularly as it relates to Roche’s
mandate of developing and delivering innovative healthcare solutions for Canadians. Ronnie has more than 43 years of extensive and varied
experience in the pharmaceutical industry. Born in Scotland, Ronnie completed his Bachelor of Science in Economics and Geography at the
University of Glasgow, then moved to Leeds, England to accept a job as a pharmaceutical sales representative. Ronnie advanced through
a series of successive sales and management positions across the industry to become the National Sales Manager for Roche in the United
Kingdom in 1988 and continued to move globally as a Product Manager in Switzerland and Deputy Divisional Director of the Pharmaceutical
Division in Japan. He moved back to Switzerland to head up a global product launch before returning to the UK as Pharmaceuticals Director.
Ronnie was appointed President and CEO of Roche Pharmaceuticals in Canada in May 2000 and became a Canadian citizen in 2008. Ronnie was
re-elected as Chairman of the Board of Directors of Innovative Medicines Canada (IMC), the national association representing Canada’s
research-based pharmaceutical companies, from 2019 to 2022. He served as Chairman of the IMC Board in 2007 and has since fulfilled two
subsequent terms as Past Chair. Prior to this, Ronnie was the Chair of the IMC Prairies Core Team and sat as Co-Chair of the Health Research
Foundation. He also served on several committees including the IMC Public Affairs, Stakeholder Relations, the British Columbia Sub-Committee,
and was Chair of the Federal Affairs/FPT Relations Standing Committee.

Michel Regnieris an experienced and respected
Operations Executive and Professional Engineer with 20+ years of progressive technical and leadership experience in the medical device,
pharmaceutical and aerospace materials manufacturing industries. Over the course of his career, he has established a successful track
record of leading cross functional technical and nontechnical teams, developing effective action plans, and working with international
partners. Prior to joining Ceapro, Mr. Regnier served in a number of roles at Oerlikon Metco (Canada) Inc